NEW YORK, Oct. 07, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Chesapeake Energy Corporation (“Chesapeake”) (NYSE:CHK) between February 27, 2015 and September 28, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of Oklahoma. If you purchased or otherwise acquired Spectrum Pharmaceuticals between February 27, 2015 and September 28, 2016, your rights may be affected by this action. To get more information go to:
http://www.zlk.com/pslra/chesapeake-energy-corporation
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
If you suffered a loss in Chesapeake Energy Corporation you have until December 5, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
The Complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Chesapeake had improperly accounted for the classification and acquisition of gas and oil properties; (2) Chesapeake lacked effective internal financial controls; and (3) subsequently, the Company's public statements were materially false and misleading at all relevant times.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



